This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

FDA Approves Device to Help Increase Access to More Lungs for Transplant

Friday, May 3, 2019

Submitted by


Source Name: US Food and Drug Administration


US Food and Drug Administration

The US FDA approved the Xvivo device for maintaining or resuscitating donor lungs prior to transplant. Interesting very high survival is reported in the control group at one year.

Add comment

Log in or register to post comments